Company Snapshot: AFAM  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Almost Family Announces Record Second Quarter 2007 Results

    EPS from Continuing Operations up 102% over 2006, Net Income up 120%

    LOUISVILLE, Ky., Aug. 6 /PRNewswire-FirstCall/ -- Almost Family, Inc.
(Nasdaq: AFAM) today announced its operating results for the three months
and six months ended June 30, 2007.
    Second Quarter 2007 Highlights
    -- Net Income From Continuing Operations was $1,984,854 or $0.35 per
       diluted share in 2007 as compared to $928,881 or $0.17 per diluted
       share in 2006
    -- Consolidated revenues increased approximately 52%
    -- Operating income from continuing operations increased 126%
    -- Net income from continuing operations increased 114%
    -- The Company's VN segment revenues grew 87%
    -- VN markets with no acquisition activity generated 27% revenue growth,
       while markets with acquisitions added $8.3 million to revenue for the
       quarter

    Year-to-date 2007 Highlights
    -- Net Income From Continuing Operations was $3,701,109 or $0.66 per
       diluted share in 2007 as compared to $1,856,532 or $0.35 per diluted
       share in 2006
    -- Consolidated revenues increased approximately 54%
    -- Operating income from continuing operations increased 119%
    -- Net income from continuing operations increased 99%
    -- The Company's VN segment revenues grew 90%
    -- VN markets with no acquisition activity generated 27% revenue growth,
       while markets with acquisitions added $16.8 million to revenue for the
       quarter
    William B. Yarmuth, AFAM's Chairman and CEO commented on the results:
    "We are extremely pleased to report our second quarter results in which
continuing EPS more than doubled from the same period last year. Our same
store revenues grew 27% clearly reflecting the high quality of care and
service that we provide to our patients. In addition to continuing our
intense focus on same store sales growth, with our strong balance sheet and
the integration of the Mederi acquisition proceeding nicely, we are very
well positioned to continue our growth in the form of both start-up
locations and additional acquisitions."
    Discussion of Quarterly Results
    Net Income From Continuing Operations grew 114% to $1,984,854 or $0.35
per diluted share for the June 2007 quarter as compared to $928,881 or
$0.17 per diluted share in the June 2006 quarter. Revenues grew 52% to
$32.7 million in the June 2007 quarter from $21.5 million in the June 2006
quarter. Revenues in the Company's "Caretenders" Visiting Nurse (VN)
segment grew 87% over the same period last year.
    The number of weighted average shares outstanding for purposes of
calculating diluted earnings per share increased 6% between periods.
    VN Revenue Comparison for the Quarter
    Due to the significant impact of acquisition activities on VN revenue
growth, the following tables are presented comparing revenue growth by
market type for the quarters ended June 30, 2007 and 2006:
    VN Revenue Comparison by   # of
    Market Type - All VN       Mkts     2007        2006      Change   Percent
     Operations

    Newly acquired markets      15  $6,442,629  $        -  $6,442,629
    Markets with in-market
     acquisitions                8   4,451,935   2,602,893   1,849,042  71.1%
      Acquisition related
       markets                  23  10,894,564   2,602,893   8,291,671

    Markets with no
     acquisition impact         24  12,649,677   9,996,237   2,653,440  26.5%

                                47 $23,544,241 $12,599,130 $10,945,111  86.9%
    VN revenues grew approximately $10.9 million between years of which 59%
came from newly acquired markets, 17% came in markets with in-market
acquisitions and 24% came from markets with no acquisition impact.
    The following table provides a comparison of revenues related specifically
to the Mederi acquisition (excludes all markets not impacted by the Mederi
acquisition):

    VN Markets Impacted by
     Mederi                      # of Mkts     2007       2006       Change

    Newly acquired Mederi
     markets                         13   $5,463,270  $       -   $5,463,270
    Mederi markets overlapping
     Almost Family Markets            7    3,936,270   2,179,028   1,757,242
         Mederi related markets      20   $9,399,540  $2,179,028  $7,220,512
    Markets with acquisitions not related to Mederi generated $1,495,024 of
revenue in the quarter ended June 30, 2007 as compared to $423,865 in 2006.
    Our Visiting Nurse segment operations located in Florida normally
experience lower admissions during the September quarter than in the other
quarters due to seasonal population fluctuations.
    Results of operations for the quarters ended June 30, 2007 and 2006 are
set forth in the tables below:
                                      June                  June
                                      2007                  2006

                                     Amount     % Rev      Amount     % Rev
    Net revenues
           Visiting Nurses         $23,544,241   72.0%  $12,599,130   58.5%
            Personal Care            9,165,611   28.0%    8,950,390   41.5%
                                   $32,709,852  100.0%  $21,549,520  100.0%
    Operating income
           Visiting Nurses          $4,795,973   20.4%   $1,886,268   15.0%
           Personal Care               951,035   10.4%      890,907   10.0%
                                     5,747,008   17.6%    2,777,175   12.9%
    Unallocated corporate expenses   2,210,196    6.8%    1,214,856    5.6%
        Operating Income             3,536,812   10.8%    1,562,319    7.2%
    Interest expense/(income)          241,220    0.7%      (22,947)  -0.1%
    Pre-tax income                   3,295,592   10.1%    1,585,266    7.4%
    Income taxes                     1,310,738    4.0%      656,385    3.0%
    Net income from continuing
      operations                    $1,984,854    6.1%     $928,881    4.3%
    Income (loss) from
     discontinued operations, net
     of tax                             (3,580)              (30,105)
        Net income                  $1,981,274    6.1%     $898,776    4.2%

    Diluted earnings per share
        Diluted shares
         outstanding(1)              5,638,665             5,322,384
        Continuing operations           $ 0.35                 $0.17
        Discontinued operations              -                 (0.01)
                                        $ 0.35                 $0.17

    (1) shares adjusted to give effect to 2-for-1 share split completed in
        January 2007

    Continuing Operations
     EBITDA                         $3,756,944   11.5%    $1,816,673    8.4%
     Effective tax rate                    39.8%                 41.4%


                                                    Change
                                                    Amount              %
    Net revenues
           Visiting Nurses                       $10,945,111          86.9%
            Personal Care                            215,221           2.4%
                                                 $11,160,332          51.8%
    Operating income
           Visiting Nurses                        $2,909,705         154.3%
            Personal Care                             60,128           6.7%
                                                   2,969,833         106.9%
    Unallocated corporate expenses                   995,340          81.9%
        Operating Income                           1,974,493         126.4%
    Interest expense/(income)                        264,167             NM
    Pre-tax income                                 1,710,326         107.9%
    Income taxes                                     654,353          99.7%
    Net income from continuing
      operations                                  $1,055,973         113.7%
    Income (loss) from discontinued
     operations, net of tax                           26,525             NM
        Net income                                $1,082,498         120.4%

    Diluted earnings per share
        Diluted shares outstanding (1)               316,281           5.9%
        Continuing operations                       $   0.18         101.7%
        Discontinued operations                            -             NM
                                                    $   0.18         120.4%

    (1) shares adjusted to give effect to 2-for-1 share split completed in
        January 2007

    Continuing Operations
     EBITDA                                       $1,940,271         106.8%
     Effective tax rate                                 (1.6%)
    Net income including discontinued operations, was $1,981,274 or $0.35
per diluted share in the quarter ended June 30, 2007 and $898,776 or $0.17
per diluted share in 2006.
    Discussion of Six-Month Results
    Net Income From Continuing Operations grew 99% to $3,701,109 or $0.66
per diluted share for the six months ended June 2007 as compared to
$1,856,532 or $0.35 per diluted share in the six months ended June 2006.
Revenues grew 54% to $64.7 million in the six months ended June 2007 from
$42.0 million in the six months ended June 2006. Revenues in the Company's
"Caretenders" Visiting Nurse (VN) segment grew 90% over the same period
last year.
    The number of weighted average shares outstanding for purposes of
calculating diluted earnings per share increased 6% between periods.
    VN Revenue Comparison for the Six Months
    Due to the significant impact of acquisition activities on VN revenue
growth, the following tables are presented comparing revenue growth by
market type for the six month periods ended June 30, 2007 and 2006:
    VN Revenue Comparison
    by Market Type - All   # of
    VN Operations          Mkts     2007         2006        Change   Percent
    Newly acquired
     markets                15  $12,973,238   $       -   $12,973,238
    Markets with in-market
     acquisitions            8    8,660,741    4,796,755    3,863,986  80.6%
      Acquisition related
       markets              23   21,633,979    4,796,755   16,837,224
    Markets with no
     acquisition impact     24   25,038,935   19,745,419    5,293,516  26.8%
                            47  $46,672,914  $24,542,174  $22,130,740  90.2%
    VN revenues grew approximately $22.1 million between years of which 59%
came from newly acquired markets, 18% came in markets with in-market
acquisitions and 24% came from markets with no acquisition impact.
    The following table provides a comparison of revenues related specifically
to the Mederi acquisition (excludes all markets not impacted by the Mederi
acquisition):

    VN Markets Impacted           # of
     by Mederi                    Mkts     2007        2006        Change

    Newly acquired
     Mederi markets                13  $11,146,800  $       -   $11,146,800
    Mederi markets
     overlapping Almost
     Family Markets                 7    7,583,932   3,907,691    3,676,241
         Mederi related markets    20  $18,730,732  $3,907,691  $14,823,041
    Markets with acquisitions not related to Mederi generated $2,903,247 of
revenue in the six months ended June 30, 2007 as compared to $889,064 in
2006.
    Results of operations for the six-month periods ended June 30, 2007 and
2006 are set forth in the tables below:
                                      June                  June
                                      2007                  2006
                                     Amount      % Rev     Amount      % Rev
    Net revenues
           Visiting Nurses         $46,672,914   72.2%  $24,542,174   58.3%
            Personal Care           17,986,252   27.8%   17,518,670   41.7%
                                   $64,659,166  100.0%  $42,060,844  100.0%
    Operating income
           Visiting Nurses          $9,284,822   19.9%   $3,918,467   16.0%
            Personal Care            1,448,988    8.1%    1,459,836    8.3%
                                    10,733,810   16.6%    5,378,303   12.8%
    Unallocated corporate expenses   4,085,721    6.3%    2,342,790    5.6%
        Operating Income             6,648,089   10.3%    3,035,513    7.2%
    Interest expense/(income)          496,928    0.8%      (60,945)  -0.1%
    Pre-tax income                   6,151,161    9.5%    3,096,458    7.4%
    Income taxes                     2,450,052    3.8%    1,239,926    2.9%
    Net income from continuing
      operations                    $3,701,109    5.7%   $1,856,532    4.4%
    Income (loss) from
     discontinued operations, net
     of tax
                                       (53,457)             (112,091)
        Net income                  $3,647,652    5.6%   $1,744,441    4.1%

    Diluted earnings per share
        Diluted shares
         outstanding (1)             5,601,807             5,299,298
        Continuing operations        $    0.66             $    0.35
        Discontinued operations          (0.01)                (0.02)
                                     $    0.65             $    0.33

    (1) shares adjusted to give effect to 2-for-1 share split completed in
        January 2007

    Continuing Operations
     EBITDA                         $7,080,101   11.0%    $3,567,250    8.5%
     Effective tax rate                  39.8%                 40.0%


                                                             Change
                                                    Amount              %
    Net revenues
           Visiting Nurses                       $22,130,740          90.2%
            Personal Care                            467,582           2.7%
                                                 $22,598,322          53.7%
    Operating income
           Visiting Nurses                        $5,366,355         137.0%
            Personal Care                            (10,848)         -0.7%
                                                   5,355,507          99.6%
    Unallocated corporate expenses                 1,742,931          74.4%
        Operating Income                           3,612,576         119.0%
    Interest expense/(income)                        557,873            NM%
    Pre-tax income                                 3,054,703          98.7%
    Income taxes                                   1,210,126          97.6%
    Net income from continuing
      operations                                  $1,844,577          99.4%
    Income (loss) from discontinued
     operations, net of tax                           58,634
                                                                         NM
        Net income                                $1,903,211         109.1%

    Diluted earnings per share
        Diluted shares outstanding (1)               302,509           5.7%
        Continuing operations                       $   0.31          88.6%
        Discontinued operations                         0.00             NM
                                                    $   0.32          97.4%

        (1) shares adjusted to give effect to 2-for-1 share split completed in
        January 2007

    Continuing Operations
     EBITDA                                       $3,512,851          98.5%
     Effective tax rate                               (0.2%)
    Net income including discontinued operations, was $3,647,652 or $0.65
per diluted share in the quarter ended June 30, 2007 and $1,744,441 or
$0.33 per diluted share in 2006.
    Non-GAAP Financial Measure
    The information provided in the tables in this release includes certain
non-GAAP financial measures as defined under Securities and Exchange
Commission (SEC) rules. In accordance with SEC rules, the Company has
provided, in the supplemental information and the footnotes to the tables,
a reconciliation of those measures to the most directly comparable GAAP
measures.
    EBITDA:
    EBITDA is defined as income before depreciation and amortization, net
interest expense and income taxes. EBITDA is not a measure of financial
performance under accounting principles generally accepted in the United
States of America. It should not be considered in isolation or as a
substitute for net income, operating income, cash flows from operating,
investing or financing activities, or any other measure calculated in
accordance with generally accepted accounting principles. The items
excluded from EBITDA are significant components in understanding and
evaluating financial performance and liquidity. Management routinely
calculates and communicates EBITDA and believes that it is useful to
investors because it is commonly used as an analytical indicator within our
industry to evaluate performance, measure leverage capacity and debt
service ability, and to estimate current or prospective enterprise value.
EBITDA is also used in measurements of borrowing availability and certain
covenants contained in our credit agreement.
    The following table sets forth a reconciliation of Continuing Operations
Net Income to EBITDA:

                                      Quarter               Six Months
                                   Ended June 30,         Ended June 30,
                                  2007        2006       2007       2006
    Net income from
     continuing operations     $1,984,854   $928,881 $3,701,109 $1,856,532
    Add back:
         Interest expense
          (income)                241,220    (22,947)   496,928    (60,945)
         Income taxes           1,310,738    656,385  2,450,052  1,239,926
         Depreciation &
          amortization            220,132    254,354    432,099    531,737
    Earnings from continuing
     operations Before
     Interest, Income Taxes,
     Depreciation &
     Amortization (EBITDA)     $3,756,944 $1,816,673 $7,080,188 $3,567,250
    Almost Family, Inc.(TM) and subsidiaries (collectively "Almost Family")
is a leading regional provider of home health services. The Company has
service locations in Florida, Kentucky, Ohio, Connecticut, Massachusetts,
Missouri, Alabama, Illinois and Indiana and (in order of revenue
significance).
    Contact: William Yarmuth or Steve Guenthner (502) 891-1000.
    All statements, other than statements of historical facts, included in
this news release, are forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements may be identified by the use of forward-looking terminology such
as "may," "will," "expect," "believe," estimate," "project," anticipate,"
"continue," or similar terms, variations of those terms or the negative of
those terms. These forward-looking statements are based on the Company's
current plans, expectations and projections about future events.
    Because forward-looking statements involve risks and uncertainties, the
Company's actual results could differ materially from any future results,
performance or achievements expressed or implied by such forward-looking
statements. The potential risks and uncertainties which could cause actual
results to differ materially include: regulatory approvals or third party
consents may not be obtained, the impact of further changes in healthcare
reimbursement systems, including the ultimate outcome of potential changes
to Medicare reimbursement for home health services and to Medicaid
reimbursement due to state budget shortfalls; the ability of the Company to
maintain its level of operating performance and achieve its cost control
objectives; changes in our relationships with referral sources; the ability
of the Company to integrate acquired operations; government regulation;
health care reform; pricing pressures from Medicare, Medicaid and other
third-party payers; changes in laws and interpretations of laws relating to
the healthcare industry; and the Company's self-insurance risks. For a more
complete discussion regarding these and other factors which could affect
the Company's financial performance, refer to the Company's various filings
with the Securities and Exchange Commission, including its filing on Form
10-K for the year ended December 31, 2006, in particular information under
the headings "Special Caution Regarding Forward-Looking Statements" and
"Risk Factors." The Company undertakes no obligation to update or revise
its forward-looking statements.


SOURCE Almost Family, Inc.




Back to Topback to top

Related links:
  • http://www.almost-family.com
  • http://www.prnewswire.com/comp/784275.html /
    CONTACT:
    William Yarmuth or Steve Guenthner,
    +1-502-891-1000, both of Almost Family, Inc.